The Risk/Benefit Analysis of Oral Anticoagulant Treatment in Atrial Fibrillation Using HAS-BLED and CHA2DS2-VASc Score

by Ionela Silivastru (Cozlea), Laurentiu Cozlea Daniel, Attila Keresztesi Arthur, Gabriela Asofie, Laurentiu Cozlea, Galafteon Oltean, Daniela Dobru
Published 2015-12-01